Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$25.6 - $45.23 $1.36 Million - $2.41 Million
-53,180 Reduced 74.2%
18,495 $741,000
Q4 2021

Feb 11, 2022

BUY
$35.36 - $41.86 $2.53 Million - $3 Million
71,675 New
71,675 $2.86 Million
Q2 2021

Aug 16, 2021

SELL
$37.95 - $49.37 $865,260 - $1.13 Million
-22,800 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$46.8 - $68.92 $2,854 - $4,204
-61 Reduced 0.27%
22,800 $1.08 Million
Q4 2020

Feb 16, 2021

SELL
$47.96 - $67.64 $23,596 - $33,278
-492 Reduced 2.11%
22,861 $1.4 Million
Q3 2020

Nov 13, 2020

SELL
$45.41 - $57.07 $1.18 Million - $1.48 Million
-25,889 Reduced 52.58%
23,353 $1.09 Million
Q2 2020

Aug 14, 2020

SELL
$42.56 - $54.98 $1.18 Million - $1.52 Million
-27,660 Reduced 35.97%
49,242 $2.5 Million
Q1 2020

May 14, 2020

SELL
$32.37 - $59.36 $2.08 Million - $3.82 Million
-64,328 Reduced 45.55%
76,902 $3.43 Million
Q4 2019

Feb 13, 2020

BUY
$32.22 - $50.07 $24,744 - $38,453
768 Added 0.55%
141,230 $6.78 Million
Q3 2019

Nov 13, 2019

BUY
$33.82 - $48.17 $1.63 Million - $2.33 Million
48,340 Added 52.47%
140,462 $4.77 Million
Q2 2019

Aug 08, 2019

BUY
$35.42 - $45.0 $1.98 Million - $2.52 Million
56,008 Added 155.09%
92,122 $4.15 Million
Q1 2019

May 13, 2019

SELL
$28.09 - $39.49 $1.19 Million - $1.67 Million
-42,234 Reduced 53.91%
36,114 $1.36 Million
Q4 2018

Feb 14, 2019

BUY
$29.83 - $46.51 $738,680 - $1.15 Million
24,763 Added 46.21%
78,348 $2.66 Million
Q3 2018

Nov 13, 2018

SELL
$33.9 - $47.77 $67,800 - $95,540
-2,000 Reduced 3.6%
53,585 $2.52 Million
Q2 2018

Aug 13, 2018

BUY
$25.7 - $47.88 $778,324 - $1.45 Million
30,285 Added 119.7%
55,585 $1.88 Million
Q1 2018

May 14, 2018

BUY
$17.46 - $32.59 $441,738 - $824,527
25,300 New
25,300 $685,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.33B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.